Reversible parkinsonism in a child after bone marrow transplantation and lipid-based amphotericin B therapy.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  The Pediatric Infectious Disease Journal

• Publication date

  1998-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00006454-199805000-00021PMID 9613664
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical MR spectroscopy: fundamentals, current applications, and future potential.

  1995cited by this paper
• Encephalopathy with parkinsonian features in children following bone marrow transplantations and high‐dose amphotericin B

  1995cited by this paper
• Clinical spectrum of secondary parkinsonism in childhood: a reversible disorder.

  1994cited by this paper
• Reversal of amphotericin‐B‐related encephalopathy

  1994cited by this paper
• Localized proton MR spectroscopy of the brain in children

  1993cited by this paper
• Amphotericin B‐associated leukoencephalopathy

  1992cited by this paper
• Acute effects of low-dose cranial irradiation on regional capillary permeability in experimental brain tumors.

  1989cited by this paper
• Akinetic mutism in a bone marrow transplant recipient following total-body irradiation and amphotericin B chemoprophylaxis. A positron emission tomographic and neuropathologic study.

  1987cited by this paper
• Long-term sequelae of cancer treatment on the central nervous system in childhood.

  1987cited by this paper
• Magnetic resonance imaging in the evaluation of treatment‐related central nervous system damage

  1986cited by this paper
• Severe central nervous system toxicity from high-dose cytarabine: expressive aphasia occurring after the second day of treatment.

  1985cited by this paper
• Neurological complications of bone marrow transplantation in childhood

  1984cited by this paper
• Cerebellar degeneration caused by high‐dose cytosine arabinoside: A clinicopathological study

  1983cited by this paper
• Leukoencephalopathy in patients treated with amphotericin B methyl ester.

  1982cited by this paper
• Central nervous system toxicity of high‐dose systemic cytosine arabinoside

  1981cited by this paper
• Distribution of doubly radiolabelled amphotericin B methyl ester and amphotericin B in the non-human primate, Macaca mulatta.

  1980cited by this paper

• Acute Movement Disorders in Childhood

  2021cites this paper
• CHAPTER 30 – Neurotoxic Effects of Pharmaceutical Agents I: Anti-infectives

  2009cites this paper
• Secondary parkinsonism: an unusual late complication of craniospinal radiotherapy given to a 16-month child.

  2003cites this paper
• Neurologic Complications in Children with Systemic Cancer

  2003cites this paper
• Parkinsonismo inducido por fármacos

  2002cites this paper
• Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system.

  2000cites this paper
• Topical Review: Acute Neurologic Complications in Children With Systemic Cancer

  2000cites this paper
• [Urgent neurological consultation in children with systemic cancer].

  1999cites this paper
• Comparative Efficacy and Distribution of Lipid Formulations of Amphotericin B in Experimental Candida albicans Infection of the Central Nervous System

  year unknowncites this paper